Health Affairs February 28, 2022
Colin A. Espie, John Torous, Troyen A. Brennan

There is enormous growth in the digital health sector, illustrated by huge capital investment, and a massive proliferation of mental and behavioral health apps and associated marketing claims. We are particularly concerned about one component of this sector, namely “software as a medical device”, which the Food and Drug Administration (FDA) defines as “software intended to be used for one or more medical purposes,….without being part of a hardware medical device,” and where the purpose is “treatment or alleviation of disease.” This new approach to treatment, increasingly referred to as digital therapeutics (DTx), has the potential to transform mental health care. The global DTx market was valued at more than $3.5 billion in 2020 and is projected to reach $23.5...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Digital Health, FDA, Govt Agencies, Mental Health, Provider, Technology
PebbleOS’s Core 2 Duo, Time 2 Are Anti Apple Watch Retro Smartwatches
Unhinged: The Virtual MSK Reckoning (and What Comes Next)
Screenagers to Silver Surfers: How each generation clicks with care
Digital Health Rewired 2025: 10 Key Talking Points
New Law Extends Telehealth Flexibilities Another 6 Months

Share This Article